4.3684
Arbutus Biopharma Corp (ABUS) 最新ニュース
Arbutus Biopharma Corporation $ABUS Shares Purchased by Two Seas Capital LP - MarketBeat
The time has not yet come to remove your chips from the table: Arbutus Biopharma Corp (ABUS) - Setenews
Why global investors buy Arbutus Biopharma Corporation (I9DN) stockWeekly Trend Summary & Community Supported Trade Ideas - Newser
Can Arbutus Biopharma Corporation (I9DN) stock hold up in economic slowdown2025 Year in Review & Real-Time Stock Entry Alerts - Newser
Is Arbutus Biopharma Corporation (I9DN) stock a buy for dividend portfoliosPortfolio Value Report & Fast Moving Stock Trade Plans - Newser
How Arbutus Biopharma Corporation (I9DN) stock trades after earningsJuly 2025 Short Interest & Capital Efficiency Focused Strategies - Newser
Why Arbutus Biopharma Corporation (I9DN) stock could outperform next yearJuly 2025 Short Interest & Safe Capital Allocation Plans - Newser
There is no way Arbutus Biopharma Corp (ABUS) can keep these numbers up - Setenews
Arbutus Biopharma (NASDAQ:ABUS) Stock Price Crosses Above 200 Day Moving Average – Here’s What Happened - Defense World
How Arbutus Biopharma Corporation (I9DN) stock reacts to new regulationsEarnings Risk Summary & Weekly Setup with High ROI Potential - newser.com
A look into Arbutus Biopharma Corp (ABUS)’s deeper side - Setenews
Why Arbutus Biopharma Corporation stock is trending among retail tradersJuly 2025 Volume & Daily Growth Stock Tips - newser.com
Arbutus Reports Major Advances in HBV Candidate as Litigation Against Moderna, Pfizer Builds Toward Trial - MyChesCo
Arbutus Biopharma Corporation stock trend outlook and recovery pathQuarterly Market Summary & Daily Price Action Insights - newser.com
How Arbutus Biopharma Corporation (I9DN) stock compares with market leadersWeekly Trade Analysis & Growth Oriented Trading Recommendations - newser.com
How Arbutus Biopharma Corporation stock compares to growth peersMarket Risk Analysis & Fast Moving Trade Plans - newser.com
Arbutus Biopharma’s (ABUS) Buy Rating Reiterated at Chardan Capital - Defense World
Quantitative breakdown of Arbutus Biopharma Corporation recent move2025 Big Picture & Reliable Intraday Trade Plans - newser.com
What indicators show strength in Arbutus Biopharma Corporation2025 Investor Takeaways & Low Volatility Stock Recommendations - newser.com
What analysts say about Arbutus Biopharma Corporation I9DN stockBull Market Opportunities & Follow Top Performers in the Community - earlytimes.in
Arbutus Biopharma (ABUS) Receives Steady Buy Rating from Chardan Capital | ABUS Stock News - GuruFocus
Arbutus Biopharma Faces Losses And Legal Battles This Quarter - Finimize
Arbutus: Q3 Earnings Snapshot - New Haven Register
Arbutus Biopharma earnings missed, revenue fell short of estimates By Investing.com - Investing.com South Africa
Arbutus Biopharma shares rise as imdusiran data shows promising results By Investing.com - Investing.com Canada
Arbutus Biopharma shares rise as imdusiran data shows promising results - Investing.com
Arbutus Biopharma earnings missed, revenue fell short of estimates - Investing.com
Arbutus (ABUS) Reports Q3 Results, Highlights Promising Imdusira - GuruFocus
Nothing is Better Than Arbutus Biopharma Corp (ABUS) stock at the moment - Setenews
Arbutus Reports Third Quarter 2025 Financial Results and Provides Corporate Update - The Manila Times
Arbutus Biopharma Corp SEC 10-Q Report - TradingView
Signal strength of Arbutus Biopharma Corporation stock in tech scannersJuly 2025 Reactions & Safe Capital Growth Plans - newser.com
大文字化:
|
ボリューム (24 時間):